Literature DB >> 16909387

X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

James M Amos-Landgraf1, Amy Cottle, Robert M Plenge, Mike Friez, Charles E Schwartz, John Longshore, Huntington F Willard.   

Abstract

X-chromosome inactivation is widely believed to be random in early female development and to result in a mosaic distribution of cells, approximately half with the paternally derived X chromosome inactive and half with the maternally derived X chromosome inactive. Significant departures from such a random pattern are hallmarks of a variety of clinical states, including being carriers for severe X-linked diseases or X-chromosome cytogenetic abnormalities. To evaluate the significance of skewed patterns of X inactivation, we examined patterns of X inactivation in a population of >1,000 phenotypically unaffected females. The data demonstrate that only a very small proportion of unaffected females show significantly skewed inactivation, especially during the neonatal period. By comparison with this data set, the degree of skewed inactivation in a given individual can now be quantified and evaluated for its potential clinical significance.

Entities:  

Mesh:

Year:  2006        PMID: 16909387      PMCID: PMC1559535          DOI: 10.1086/507565

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  A longitudinal study of X-inactivation ratio in human females.

Authors:  Ionel Sandovici; Anna K Naumova; Mark Leppert; Yendi Linares; Carmen Sapienza
Journal:  Hum Genet       Date:  2004-08-28       Impact factor: 4.132

2.  Expression of the gene defect in X-linked agammaglobulinemia.

Authors:  M E Conley; P Brown; A R Pickard; R H Buckley; D S Miller; W H Raskind; J W Singer; P J Fialkow
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

3.  Primordial cell pool size and lineage relationships of five human cell types.

Authors:  P J Fialkow
Journal:  Ann Hum Genet       Date:  1973-07       Impact factor: 1.670

4.  Glucose-6-phosphate dehydrogenase mosaicism for studying the development of blood cell precursors.

Authors:  E Gandini; S M Gartler
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

5.  Controlling elements in the mouse X chromosome.

Authors:  B M Cattanach; J H Isaacson
Journal:  Genetics       Date:  1967-10       Impact factor: 4.562

6.  Structural anomalies of the X chromosome and inactivation center.

Authors:  M G Mattei; J F Mattei; I Vidal; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.

Authors:  B R Migeon; H W Moser; A B Moser; J Axelman; D Sillence; R A Norum
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  Skewed X-chromosome inactivation is associated with trisomy in women ascertained on the basis of recurrent spontaneous abortion or chromosomally abnormal pregnancies.

Authors:  C L Beever; M D Stephenson; M S Peñaherrera; R H Jiang; D K Kalousek; M Hayden; L Field; C J Brown; W P Robinson
Journal:  Am J Hum Genet       Date:  2002-12-20       Impact factor: 11.025

9.  Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome.

Authors:  W L Nyhan; B Bakay; J D Connor; J F Marks; D K Keele
Journal:  Proc Natl Acad Sci U S A       Date:  1970-01       Impact factor: 11.205

10.  Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe.

Authors:  M F Fey; S Liechti-Gallati; A von Rohr; B Borisch; L Theilkäs; V Schneider; M Oestreicher; S Nagel; A Ziemiecki; A Tobler
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

View more
  114 in total

1.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Extremely skewed X-chromosome inactivation is increased in pre-eclampsia.

Authors:  Elif Uz; Ismail Dolen; Atakan R Al; Tayfun Ozcelik
Journal:  Hum Genet       Date:  2006-11-07       Impact factor: 4.132

3.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 4.  X chromosome inactivation and female predisposition to autoimmunity.

Authors:  Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 5.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

6.  X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the fragile X-related disorders: implications for the mechanism of repeat expansion.

Authors:  Rachel Adihe Lokanga; Xiao-Nan Zhao; Ali Entezam; Karen Usdin
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

Review 7.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

8.  Skewed X inactivation in Lesch-Nyhan disease carrier females.

Authors:  Rosa J Torres; Juan G Puig
Journal:  J Hum Genet       Date:  2017-09-14       Impact factor: 3.172

9.  Comparison of X-chromosome inactivation patterns in multiple tissues from human females.

Authors:  D C Bittel; M F Theodoro; N Kibiryeva; W Fischer; Z Talebizadeh; M G Butler
Journal:  J Med Genet       Date:  2007-12-21       Impact factor: 6.318

10.  Skewed X-chromosome inactivation in scleroderma.

Authors:  Elif Uz; Laurence S Loubiere; Vijayakrishna K Gadi; Zeynep Ozbalkan; Jeffrey Stewart; J Lee Nelson; Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.